U.S. Markets open in 13 hrs, 36 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,387.61 | 936.42 | 11.08% |
| NASDAQ | 1,844.25 | 194.74 | 11.81% |
| S&P 500 | 1,003.35 | 104.13 | 11.58% |
| Day Low 10:18 AM EDT | 3.29 | |
|---|---|---|
| Day High 01:49 PM EDT | 3.71 |
|
| Range | 0.42 | |
| Volume | 335,433 | |
| 30-Day Avg. Vol. | 418,000 |
|
| Difference | -19.75% | |
| Market Cap. | 139.14 M | |
| Change | 18.06 M | |
| Shares Out. | 38.43 M | |
| Percent Traded | 0.87% | |
| Revenue (LFY) | 1.22 M | |
| Earnings (TTM) | -207.29 M | |
| Next Earnings | 10/27/2008 |
|
| EPS (TTM) | -5.18 |
| 52-Wk Low 10/10/08 | 2.55 | |
|---|---|---|
| 52-Wk High 12/3/07 | 13.07 |
|
| Range | 10.52 | |
| Prev. Close 10/10/08 | 3.15 | |
| Today's Open | 3.34 | |
| Change | 6.03% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.8583 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -1.00 |
For Neurocrine Biosciences, biology is all chemistry. The development-stage biotech develops treatments for neurological and endocrine-related diseases, such as insomnia, depression, and pain. Lead drug ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.553 3/31/08 | -0.55 3/31/08 |
0.003
Beat
|
| Last Quarter | -0.518 6/30/08 | -0.55 6/30/08 |
-0.032
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 734,000.00 | 1.22 M |
| Gross Profit | -11.95 M | 28.67 M |
| Operating Income | -20.12 M | -111.34 M |
| Net Income | -20.97 M | -207.30 M |
